Saha, Subbroto KumarRiazul Islam, S. M.Abdullah-Al-Wadud, M.Islam, SaifulAli, FarmanPark, Kyoung Sik2024-05-062024-05-062019-03-13Saha, S K, Riazul Islam, S M, Abdullah-Al-Wadud, M, Islam, S, Ali, F & Park, K S 2019, 'Multiomics analysis reveals that GLS and GLS2 differentially modulate the clinical outcomes of cancer', Journal of Clinical Medicine, vol. 8, no. 3, 355. https://doi.org/10.3390/jcm80303552077-0383ORCID: /0000-0003-2968-9561/work/142570805https://hdl.handle.net/2164/23409Acknowledgements: This work was supported by the Deanship of Scientific Research at King Saud University through Research Group Grant RGP-1438-044.285081768engSDG 3 - Good Health and Well-beingCancer therapyClinical outcomesGLSGLS2GlutaminaseMultiomicsPrognostic biomarkersR MedicineGeneral MedicineSupplementary Datahttp://www.mdpi.com/2077-0383/8/3/355/s1RJournal article10.3390/jcm8030355http://www.scopus.com/inward/record.url?scp=85075304743&partnerID=8YFLogxK83